Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 213 of 1,261
  1. US 11566224

    Dendritic cell generator

    Northwestern University · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  2. US 11566228

    Hemangio-colony forming cells

    Astellas Institute for Regenerative Medicine · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  3. US 11564884

    Cationic block polymer micelles for delivery of biological agents

    Regents of the University of Minnesota · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  4. US 11566255

    Expression of PEDV sequences in plants and plant produced vaccine for same

    Mazen Animal Health, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  5. US 11566230

    Universal donor cells

    CRISPR THERAPEUTICS AG · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  6. US 11566041

    Nucleotide prodrug compounds

    Ligand Pharmaceuticals Incorporated · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  7. US 11566032

    Radio-protective and chemo-protective substituted thiols

    TONIX PHARMACEUTICALS HOLDING CORP · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  8. US 11566011

    Highly purified pharmaceutical grade tasimelteon

    VANDA PHARMACEUTICALS INC. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  9. US 11565096

    Delivery system for a pharmaceutical, holistic or medicinal component

    Herphoric, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  10. US 11566015

    Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  11. US 11564997

    Materials and methods for treatment of friedreich ataxia and other related disorders

    CRISPR THERAPEUTICS AG · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  12. US 11565001

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  13. US 11565107

    Tolerable and minimally invasive skin electroporation device

    Inovio Pharmaceuticals, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  14. US 11564916

    Pharmaceutical composition and administrations thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  15. US 11564981

    Vaccine for prevention of necrotic enteritis in poultry

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  16. US 11564926

    Methods of synthesizing thyroid hormone analogs and polymorphs thereof

    Madrigal Pharmaceuticals, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  17. US 11566007

    Ras inhibitors

    Revolution Medicines, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  18. US 11564891

    Chloroquine gel and preparation method and application thereof

    GUANGZHOU HYBRIBIO BIOTECH LTD. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  19. US 11566242

    Methods and compositions for reprogramming cells

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  20. US 11564927

    Therapeutic compositions, combinations, and methods of use

    VERASTEM, INC. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  21. US 11559588

    Materials and methods for treatment of Spinocerebellar Ataxia Type 1 (SCA1) and other Spinocerebellar Ataxia Type 1 Protein (ATXN1) gene related conditions or disorders

    CRISPR THERAPEUTICS AG · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  22. US 11560368

    Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  23. US 11560370

    5-membered heteroaryl carboxamide compounds for treatment of HBV

    ASSEMBLY BIOSCIENCES, INC. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  24. US 11560372

    Heterocyclic compounds useful as modulators of acetylcholine receptors

    Takeda Pharmaceutical Company Limited · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.